Pfizer

METHOTREXATE

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / METHOTREXATE – J9260

Manufacturer:

Pfizer

Name:

METHOTREXATE

HCPCS Code Descriptor:

Methotrexate sodium, 50 mg

Category:

J Code

HCPCS:

J9260

NDC(s):

00703-3671-01, 00703-3675-01, 00703-3678-01, 00703-3678-81, 16729-0277-03, 16729-0277-30, 16729-0277-35, 00143-9367-01, 67457-0480-40, 67457-0466-10, 63323-0123-10, 63323-0122-50, 63323-0122-59, 61703-0408-41, 61703-0408-25, 61703-0350-38, 61703-0350-10, 61703-0124-40, 00143-9830-01, 00143-9519-10

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Injection

About:

METHOTREXATE is an Oncology drug manufactured by Pfizer and administered via the Injection route of administration. The J Code: J9260 is aligned to the drug METHOTREXATE.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/84

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Methotrexate sodium inj

Billing and Coding Guide:

Not Found

Patient Assistance:

https://azuritysolutions.com/patients/xatmep/#product

https://www.rasuvo.com/patient-resources/